Marc Rivière is an experienced executive with a track record in building and managing clinical programs, encompassing all aspects of drug development. At TVM Capital Life Science, he focuses on evaluation of deal opportunities and investment management for therapeutics and works closely with Eli Lilly & Co.
Access investment thesis, focus areas, bio, and contact details for Marc Rivière, MD and 22,000+ other VC professionals.